Media Summary: In this video, Eytan Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses In this video, Liang Wang, PhD, Beijing Tongren Hospital, Beijing, China, discusses the results of Reid Merryman, MD, Dana-Farber Cancer Institute, Boston, MA, presents the preliminary results of

A Phase Ii Trial Evaluating - Detailed Analysis & Overview

In this video, Eytan Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses In this video, Liang Wang, PhD, Beijing Tongren Hospital, Beijing, China, discusses the results of Reid Merryman, MD, Dana-Farber Cancer Institute, Boston, MA, presents the preliminary results of Watch the full course and our most up-to-date content here: Create a free account to track ... HealthDay interviews Benjamin Diamond, MD, Asst. Professor at the Miller School of Medicine at the University of Miami, about ... Andrew Davies, MRCP, PhD from University of Southampton, Southampton, UK discusses his participation in the joint symposia ...

Fadi Haddad, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses results from Swetha Thiruvengadam, MD, City of Hope, Duarte, CA, shares findings from the interim analysis of Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, outlines the evolution of ... Pisit “Duke” Pitukcheewanont, MD, Chief Medical Officer for Lumos Pharma, discusses Ciara Freeman, MD, PhD, Moffitt Cancer Center, Tampa, FL, discusses the QUINTESSENTIAL

Photo Gallery

A Phase II trial evaluating E7820 in patients with AML with splicing factor mutations
A Phase II trial evaluating CD19/CD22 bispecific CAR T-cell therapy in R/R DLBCL
A Phase II trial evaluating rituximab and epcoritamab as first-line therapy for high-tumor burden FL
Phases of Clinical Trials: Explained
ReKInDLE Phase 2 Trial: Evaluating a New Quadruplet Regimen for R/R Multiple Myeloma
Results of Phase II trial to assess the efficacy and safety of idelalisib
The Phase 2 ASC2ESCALATE Trial Evaluating Asciminib for CML Patients | David Andorsky, MD | #ASH2024
A Phase II trial of asciminib for newly diagnosed chronic myeloid leukemia
Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL
Interim results of a Phase II trial evaluating ISA-LEN for HR-SMM
Phase 2 Trial Evaluating LUM-201 for Treatment of Growth Hormone Deficiency
The Four Phases of Clinical Trials | Diversity in Clinical Trials | AKF
Sponsored
Sponsored
View Detailed Profile
A Phase II trial evaluating E7820 in patients with AML with splicing factor mutations

A Phase II trial evaluating E7820 in patients with AML with splicing factor mutations

In this video, Eytan Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses

A Phase II trial evaluating CD19/CD22 bispecific CAR T-cell therapy in R/R DLBCL

A Phase II trial evaluating CD19/CD22 bispecific CAR T-cell therapy in R/R DLBCL

In this video, Liang Wang, PhD, Beijing Tongren Hospital, Beijing, China, discusses the results of

Sponsored
A Phase II trial evaluating rituximab and epcoritamab as first-line therapy for high-tumor burden FL

A Phase II trial evaluating rituximab and epcoritamab as first-line therapy for high-tumor burden FL

Reid Merryman, MD, Dana-Farber Cancer Institute, Boston, MA, presents the preliminary results of

Phases of Clinical Trials: Explained

Phases of Clinical Trials: Explained

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

ReKInDLE Phase 2 Trial: Evaluating a New Quadruplet Regimen for R/R Multiple Myeloma

ReKInDLE Phase 2 Trial: Evaluating a New Quadruplet Regimen for R/R Multiple Myeloma

HealthDay interviews Benjamin Diamond, MD, Asst. Professor at the Miller School of Medicine at the University of Miami, about ...

Sponsored
Results of Phase II trial to assess the efficacy and safety of idelalisib

Results of Phase II trial to assess the efficacy and safety of idelalisib

Andrew Davies, MRCP, PhD from University of Southampton, Southampton, UK discusses his participation in the joint symposia ...

The Phase 2 ASC2ESCALATE Trial Evaluating Asciminib for CML Patients | David Andorsky, MD | #ASH2024

The Phase 2 ASC2ESCALATE Trial Evaluating Asciminib for CML Patients | David Andorsky, MD | #ASH2024

Dr David Andorsky discusses

A Phase II trial of asciminib for newly diagnosed chronic myeloid leukemia

A Phase II trial of asciminib for newly diagnosed chronic myeloid leukemia

Fadi Haddad, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses results from

Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL

Interim analysis of a Phase II trial of epcoritamab plus lenalidomide in treatment-naive FL

Swetha Thiruvengadam, MD, City of Hope, Duarte, CA, shares findings from the interim analysis of

Interim results of a Phase II trial evaluating ISA-LEN for HR-SMM

Interim results of a Phase II trial evaluating ISA-LEN for HR-SMM

Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, outlines the evolution of ...

Phase 2 Trial Evaluating LUM-201 for Treatment of Growth Hormone Deficiency

Phase 2 Trial Evaluating LUM-201 for Treatment of Growth Hormone Deficiency

Pisit “Duke” Pitukcheewanont, MD, Chief Medical Officer for Lumos Pharma, discusses

The Four Phases of Clinical Trials | Diversity in Clinical Trials | AKF

The Four Phases of Clinical Trials | Diversity in Clinical Trials | AKF

There are usually four phases of

QUINTESSENTIAL: a Phase II trial of arlo-cel, a GPRC5D-directed CAR T-cell therapy, in R/R myeloma

QUINTESSENTIAL: a Phase II trial of arlo-cel, a GPRC5D-directed CAR T-cell therapy, in R/R myeloma

Ciara Freeman, MD, PhD, Moffitt Cancer Center, Tampa, FL, discusses the QUINTESSENTIAL